David S. Kozin Posted May 18, 2011 Report Share Posted May 18, 2011 HONOLULU -- Lithium carbonate added to guideline-directed mood stabilizer therapy for bipolar disorder provided little benefit but increased the adverse effects in a major trial, researchers said here. View the full article Link to comment Share on other sites More sharing options...
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!Register a new account
Already have an account? Sign in here.Sign In Now